We recently published Jim Cramer’s Surprised About US Travel As He Discusses These 18 Stocks. In this article, we are going ...

Three stocks that offer yields of more than 3% and which are trading near their 52-week lows today are Merck (NYSE: MRK), NextEra Energy (NYSE: NEE), and Comcast (NASDAQ: CMCSA). Here's why they can ...

Merck unveiled encouraging Phase 3 KEYNOTE-689 trial results for KEYTRUDA at the AACR 2025 Meeting, sparking investor ...

The firm reported revenues of $15.53 billion and adjusted earnings per share of $2.22, surpassing consensus predictions of ...

Merck (NYSE:MRK) recently announced promising results from its Phase 3 KEYNOTE-689 trial of KEYTRUDA, presented at the AACR Annual Meeting, which seems likely to have bolstered investor confidence, ...

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.

Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold ...

Selling, general and administrative expenses were $2.6 billion in the first quarter, Merck noted, an increase of 3% compared with the first quarter of 2024. The increase was primarily due to higher ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid a roiling trade war between the US ...

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...

Merck also cited "increasingly meaningful" sales contributions from two recently launched drugs. They are Winrevair, which is ...

With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...